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calcium handling abnormalities in sympathetic hyperactivity-induced
heart failure mice. J Appl Physiol 104: 103–109, 2008. First published
November 1, 2007; doi:10.1152/japplphysiol.00493.2007.—Exercise
training (ET) is a coadjuvant therapy in preventive cardiology. It
delays cardiac dysfunction and exercise intolerance in heart failure
(HF); however, the molecular mechanisms underlying its cardiopro-
tection are poorly understood. We tested the hypothesis that ET would
prevent Ca2 handling abnormalities and ventricular dysfunction in
sympathetic hyperactivity-induced HF mice. A cohort of male wild-
type (WT) and congenic 2A/2C-adrenoceptor knockout (2A/
2CARKO) mice with C57BL6/J genetic background (3–5 mo of age)
were randomly assigned into untrained and exercise-trained groups.
ET consisted of 8-wk swimming session, 60 min, 5 days/wk. Frac-
tional shortening (FS) was assessed by two-dimensional guided M-
mode echocardiography. The protein expression of ryanodine receptor
(RyR), phospho-Ser2809-RyR, sarcoplasmic reticulum Ca2 ATPase
(SERCA2), Na/Ca2 exchanger (NCX), phospholamban (PLN),
phospho-Ser16-PLN, and phospho-Thr17-PLN were analyzed by
Western blotting. At 3 mo of age, no significant difference in FS and
exercise tolerance was observed between WT and 2A/2CARKO
mice. At 5 mo, when cardiac dysfunction is associated with lung
edema and increased plasma norepinephrine levels, 2A/2CARKO
mice presented reduced FS paralleled by decreased SERCA2 (26%)
and NCX (34%). Conversely, 2A/2CARKO mice displayed in-
creased phospho-Ser16-PLN (76%) and phospho-Ser2809-RyR (49%).
ET in 2A/2CARKO mice prevented exercise intolerance, ventricular
dysfunction, and decreased plasma norepinephrine. ET significantly
increased the expression of SERCA2 (58%) and phospho-Ser16-PLN
(30%) while it restored the expression of phospho-Ser2809-RyR to WT
levels. Collectively, we provide evidence that improved net balance of
Ca2 handling proteins paralleled by a decreased sympathetic activity
on ET are, at least in part, compensatory mechanisms against deteri-
orating ventricular function in HF.
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IT IS WIDELY RECOGNIZED that exercise training is effective in
reducing a number of cardiovascular risk factors (9, 32).
Moreover, accumulated evidence shows that exercise training
is an important strategy for the prevention and treatment of
cardiovascular diseases (11, 37). In heart failure (HF), exercise
training improves patient outcome by increasing exercise tol-
erance (20, 25) and reducing dyspnea and fatigue (18). How-
ever, whether exercise training has any effect in developing HF
is less studied. Indeed, cellular adaptations of the exercised
myocardium are not fully understood, but increased myocyte
contractility and calcium sensitivity have been associated with
an improved heart function (22, 34).
Several Ca2 handling proteins are involved in the mainte-
nance of normal cardiac Ca2 homeostasis and contractile
function. Among these proteins, sarcoplasmic reticulum Ca2
ATPase (SERCA2), ryanodine receptor (RyR), and Na/Ca2
exchanger are responsible for the balance between sarcoplas-
mic Ca2 uptake and release, and extrusion by sarcolemma,
respectively (3, 4, 23). Ca2 uptake by SERCA2 is regulated
by a phosphorylatable protein, phospholamban (PLN), which
in its dephosphorylated form inhibits SERCA2 activity (15).
Abnormal Ca2 homeostasis by perturbation in the expression
or function of these major Ca2-regulating proteins has been
described in severe HF (2, 6, 15, 33). In a recent study, we
found that exercise training improved the net balance of car-
diac Ca2 proteins involved in transsarcolemmal flux and
sarcoplasmic reticulum reuptake of Ca2 in mice lacking both
2A/2C-adrenoceptors (2A/2CARKO), in which sympa-
thetic hyperactivity causes HF (7, 34). At 7 mo of age, when
2A/2CARKO mice display severe HF, exercise training re-
stored cardiac Na/Ca2 exchanger expression levels, and
increased SERCA2, and phosphorylated PLN at both residues
Ser16 and Thr17 expression levels, which resulted in improve-
ment in left ventricular function. These findings suggest that
the improvement in intracellular Ca2 regulation is a molecular
mechanism underlying the benefits of exercise training on
overall ventricular function in severe HF (34). Just as impor-
tant, one might expect that exercise training before the devel-
opment of HF would display a protective role preventing Ca2
handling abnormalities and preserving cardiac function. How-
ever, the potential involvement of Ca2 handling proteins in
exercise-induced cardioprotection remains to be elucidated.
The present investigation was undertaken to test the hypoth-
eses that exercise training would decrease sympathetic activity
and delay the onset of ventricular dysfunction in
2A/2CARKO mice. In addition, exercise training would pre-
vent the alterations in the expression of Ca2 handling proteins
involved in transsarcolemmal Ca2 flux, Ca2 reuptake, and
release by sarcoplasmic reticulum in developing HF in this
genetic model. Briefly, we found that exercise training mark-
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edly delayed the onset of cardiac dysfunction in 2A/
2CARKO mice. The molecular basis for this cardioprotection
includes a positive balance of cardiac Ca2 handling proteins,
which might be favored by the decreased sympathetic hyper-
activity after exercise training in this genetic model.
MATERIALS AND METHODS
Sampling
Animal care. A cohort of male wild-type (WT) and congenic
2A/2CARKO mice with C57Bl6/J genetic background aged 3–5 mo
were studied. In 2A/2CARKO mice, cardiac function is preserved
until 3 mo of age with no signs of lung water retention, whereas at 5
mo, cardiomyopathy is associated with a modest but significantly
increased water retention in lungs (25% vs. 5-mo-old WT, P  0.05),
which suggests pulmonary edema at this age. Genotypes were deter-
mined by PCR on genomic DNA obtained from tail biopsies using
primers to detect the intact and disrupted genes.
Mice were maintained in a light-controlled (12-h light cycle) and
temperature-controlled (22°C) environment and were fed a pellet
rodent diet (Nuvital Nutrientes S/A, Curitiba, PR Brazil) ad libitum
and had free access to water. WT and 2A/2CARKO mice were
randomly assigned into untrained and exercise-trained groups. This
study accorded to Ethical Principles in animal research adopted by
Brazilian College of Animal Experimentation (www.cobea.org.br). In
addition this study was approved by the University of Sao Paulo
Ethical Committee (CEP no. 004).
Measurements and Procedures
Exercise training protocol. Exercise training consisted of 5 day/wk
swimming sessions with gradually increased duration to 60 min for 8
wk in a swimming warmed-water (30–32°C) apparatus adapted for
mice (10). The training sessions were performed during the dark cycle
of the mice. Untrained mice were placed in the swimming apparatus
for 5 min twice a week to mimic the water stress associated with the
experimental protocol and handling. This swimming protocol has
been characterized previously as low to moderate intensity and long
duration due to improvement in muscle oxidative capacity and resting
bradycardia (10).
Graded treadmill exercise test. Exercise capacity, estimated by
total distance run, was evaluated using a graded treadmill exercise
protocol for mice. After being adapted to treadmill exercises over 1
wk (10 min of exercise session), mice were placed in the treadmill
streak and allowed to acclimatize for at least 30 min. Exercise began
at 6 m/min with no grade and increased by 3 m/min every 3 min
thereafter until exhaustion. The graded treadmill exercise test was
performed in WT and 2A/2CARKO mice before and after the
exercise training period.
Cardiovascular measurements. Heart rate (HR) was determined
noninvasively using a computerized tail-cuff system (BP 2000 Vis-
itech Systems) described elsewhere (17). Mice were acclimatized to
the apparatus during daily sessions over 6 days, 1 wk before starting
the experimental period. HR measurements were obtained serially in
WT and 2A/2CARKO mice once a week throughout the 8 wk of
experiment.
Noninvasive cardiac function was assessed by two-dimensional
guided M-mode echocardiography, in halothane-anesthetized WT and
2A/2CARKO mice, before and after the experimental period.
Briefly, mice were positioned in the supine position with front paws
wide open, and an ultrasound transmission gel was applied to the
precordium. Transthoracic echocardiography was performed using an
Acuson Sequoia model 512 echocardiographer equipped with a 14-
MHz linear transducer. Left ventricle systolic function was estimated
by fractional shortening as follows:
fractional shortening % LVEDD LVESD/LVEDD 100
where LVEDD means left ventricular end-diastolic dimension, and
LVESD means left ventricular end-systolic dimension.
Plasma norepinephrine levels. Plasma norepinephrine was measured
by HPLC using ion-pair reverse-phase chromatography coupled with
electrochemical detection (0.5 V) as described by Monte et al. (29).
Antibodies. Mouse monoclonal antibodies to SERCA2 (1:2,500),
PLN (1:500), RyR (1:5,000), and Na/Ca2 exchanger (1:2,000) were
obtained from Affinity Bioreagents (Golden, CO); rabbit polyclonal
phospho-Ser 2809-RyR2 (1:2,000), phospho-Ser16-PLN (1:5,000), and
phospho-Thr17-PLN (1:5,000) were obtained by Badrilla (Leeds, UK).
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 1:2,000) was ob-
tained from Advanced Immunochemical (Long Beach, CA). Targeted
bands were normalized to cardiac GAPDH.
Western blot analysis. Left ventricular homogenates were analyzed
by Western blotting to compare SERCA2, PLN, phospho-Ser16-PLN,
phospho-Thr17-PLN, Na/Ca2 exchanger, RyR, and phospho-
Ser2809-RyR. Briefly, liquid nitrogen-frozen ventricles isolated from
WT and 2A/2CARKO mice were homogenized in a buffer contain-
ing 50 mM potassium phosphate buffer (pH 7.0), 0.3 M sucrose, 0.5
mM DTT, 1 mM EDTA (pH 8.0), 0.3 mM PMSF, 10 mM NaF, and
phosphatase inhibitor cocktail (1:100, Sigma-Aldrich; Saint Louis,
MO). Samples were subjected to SDS-PAGE in polyacrylamide gels
(6% or 10% depending on protein molecular weight). After electro-
phoresis, proteins were electrotransferred to nitrocellulose membrane
(Amersham Biosciences; Piscataway, NJ). Equal loading of samples
(50 g) and even transfer efficiency were monitored with the use of
0.5% Ponceau S staining of the blot membrane. The blotted mem-
brane was then blocked (5% nonfat dry milk, 10 mM Tris HCl, pH
7.6, 150 mM NaCl, and 0.1% Tween 20) for 2 h at room temperature
and incubated with specific antibodies overnight at 4°C. Binding of
the primary antibody was detected with the use of peroxidase-conju-
gated secondary antibodies (rabbit or mouse depending on the protein,
1:10,000, for 1 h:30 min at room temperature) and developed using
enhanced chemiluminescence (Amersham Biosciences) detected by
autoradiography. Quantification analysis of blots was performed with
the use of Scion Image software (Scion based on NIH image).
Statistical Analysis
Data are presented as means 	 SE. Two-way ANOVA for repeated
measurements with post hoc testing by Tukey (Statistica software,
StatSoft, Tulsa, OK) was used to compare the effect of training
(untrained and exercise trained) and genotype (WT and 2A/
2CARKO) on distance run, fractional shortening, and HR measure-
ments along the training period. Two-way ANOVA with post hoc
testing by Tukey (Statistica software, StatSoft) was used to compare
the effect of training (untrained and exercise trained) and genotype
(WT and 2A/2CARKO) on plasma norepinephrine levels and pro-
tein expression levels. Statistical significance was considered
achieved when the value of P was 0.05.
RESULTS
Effect of Exercise Training on Exercise Tolerance, Cardiac
Contractility, and Plasma Norepinephrine Levels
At 3 mo of age, there was no difference in distance run and
fractional shortening between WT and 2A/2CARKO mice
(Fig. 1). However, at 5 mo of age, 2A/2CARKO mice
displayed exercise intolerance and systolic dysfunction com-
pared with age-matched WT mice. Exercise training in
2A/2CARKO mice not only suppressed the decrease in ex-
ercise tolerance, but also increased it towards exercise-trained
WT mice (Fig. 1A). In addition, exercise training prevented the
systolic dysfunction in 2A/2CARKO mice (Fig. 1B).
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2A/2CARKO mice displayed baseline tachycardia com-
pared with age-matched WT mice (Fig. 2A). Exercise training
significantly decreased baseline HR in both WT and 2A/
2CARKO mice from the 4th week to the end of the exercise
training period. The reduction of HR in 2A/2CARKO was so
remarkable that it reached untrained WT levels at the 5th week
of training (Fig. 2A). 2A/2CARKO mice displayed increased
plasma norepinephrine levels compared with WT mice (Fig.
2B). Exercise training significantly decreased plasma norepi-
nephrine in 2A/2CARKO mice toward untrained WT levels
(Fig. 2B).
Expression of Proteins Involved in Sarcoplasmic
Ca2 Release
As hyperphosphorylation of RyR is associated with del-
eterious effect of cardiac sympathetic hyperactivity (6, 33),
we investigated whether RyR is hyperphosphorylated in our
2A/2CARKO mice, and whether exercise training by de-
creasing sympathetic activity would restore RyR phosphor-
ylation to WT mice levels.
While RyR expression remained unchanged among the
four groups studied (Fig. 3, A and B), the phospho-Ser2809-
RyR expression levels were significantly increased by 49%
in 2A/2CARKO mice compared with age-matched WT
mice (Fig. 3, A and C). Phospho-Ser2809- RyR expression
levels remained unchanged in exercise-trained WT mice.
However, exercise training in 2A/2CARKO mice de-
creased phospho-Ser2809-RyR expression toward WT levels
(Fig. 3, A and C).
Expression of Proteins Involved in Transsarcolemmal Flux
and Sarcoplasmic Reuptake of Ca2
Since downregulation of cardiac SERCA2 expression is
associated with clinical signs of HF (12), we investigated
whether sympathetic hyperactivity in our genetic model would
alter the expression of SERCA2, Na/Ca2 exchanger, PLN,
phospho-Ser16-PLN, and phospho-Thr17-PLN. Additionally,
we tested whether exercise training would prevent these alter-
ations in 2A/2CARKO mice.
GAPDH protein levels were not different among the four
groups studied. The expression of SERCA2 and Na/Ca2
exchanger was reduced in untrained 2A/2CARKO mice by
26% and 34%, respectively (Fig. 4, A–C) compared with
untrained WT. Exercise training caused no effect on Na/Ca2
exchanger expression levels in 2A/2CARKO mice (Fig. 4, A
and C) but significantly increased SERCA2 (Fig. 4, A and B)
Fig. 2. Heart rate (HR, A) and plasma norepinephrine levels (NE, B) in
untrained and exercise-trained wild type (WTUN and WTT, respectively), and
2A/2CARKO (DKOUN and DKOT, respectively) mice. Note that exercise
training decreased HR and plasma NE levels in 2A/2CARKO mice toward
that of untrained WT mice. As expected, WTT displayed resting bradycardia.
Data are presented as mean 	 SE. *P  0.05 vs. basal levels; #P  0.05 vs.
untrained group; †P  0.05 vs. WTUN group; ‡P  0.05 vs. WTT group.
Fig. 1. Exercise capacity (A) represented by maximal distance run, and
fractional shortening (FS, B) used as an index of systolic function, were
evaluated at 3 and 5 mo of age in untrained and exercise-trained wild-type
mice (WTUN and WTT, respectively), and untrained and exercise-trained
2A/2C-adrenoceptor knockout (2A/2CARKO) mice (DKOUN and DKOT,
respectively). Note that exercise training significantly improved distance run
and FS in 2A/2CARKO mice. Data are presented as means 	 SE. *P  0.05
vs. 3 mo of age; #P  0.05 vs. WTUN group.
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expression. This increase in SERCA2 expression was so dra-
matic that it reached untrained WT mice levels. In WT mice,
exercise training did not change SERCA2 or Na/Ca2 ex-
changer expression levels.
To evaluate the effect of exercise training on the balance
between Ca2 reuptake by SERCA2 and Ca2 transsarcolem-
mal elimination by Na/Ca2 exchanger, we calculated the
SERCA2-to-Na/Ca2 exchanger ratio (SERCA2:NCX ratio).
SERCA2:NCX ratio was similar in untrained 2A/2CARKO
and WT mice (Fig. 4, A and D). In 2A/2CARKO mice,
exercise training significantly increased SERCA2:NCX ratio
(Fig. 4, A and D). In WT mice, exercise training caused no
change in SERCA2:NCX ratio.
As PLN controls the apparent Ca2 affinity of SERCA2
(24), we additionally evaluated the expression of PLN and
phosphorylated PLN at both Ser16 and Thr17 residues in
2A/2CARKO mice. PLN and phospho-Thr17-PLN expres-
sions were similar among all groups studied (Fig. 5, A, B,
and D). Phospho-Ser16-PLN was increased by 76% in un-
trained 2A/2CARKO mice compared with untrained WT
mice (Fig. 5, A and C). Although exercise training had no
impact on PLN and phospho-Thr17-PLN expression levels in
either WT or 2A/2CARKO mice, its effect on phospho-Ser
16
-PLN expression levels was remarkable. Exercise training
Fig. 4. Sarcoplasmic reticulum Ca2 ATPase (SERCA2) and Na/Ca2
exchanger (NCX) expression and SERCA:NCX ratio in untrained and exer-
cise-trained WT, and DKO mice. Data are presented as means 	 SE.
A: representative blots of SERCA2, NCX, and GAPDH from untrained and
exercise-trained WT and DKO mice. B–D: SERCA2, NCX expression, and
SERCA2:NCX ratio, respectively. Targeted bands were normalized to cardiac
GAPDH. *P  0.05 vs. untrained group; #P  0.05 vs. WTUN group.
Fig. 3. Ryanodine (RyR) and phospho-Ser2809-RyR expression in untrained
and exercise-trained WT, and 2A/2CARKO (DKO) mice. Data are presented
as means 	 SE. A: representative blots of RyR and phospho-Ser2809-RyR from
untrained (WTUN) and exercise-trained WT (WTT) and untrained (DKOUN)
and trained DKO (DKOT) mice. B and C: RyR and phospho-Ser2809-RyR,
respectively. *P  0.05 vs. untrained group; #P  0.05 vs. WTUN group.
106 EXERCISE TRAINING DELAYS CARDIAC DYSFUNCTION IN MICE
J Appl Physiol • VOL 104 • JANUARY 2008 • www.jap.org
increased phospho-Ser 16-PLN expression in both WT and
2A/2CARKO mice (Fig. 5, A and C).
DISCUSSION
A wealth of data indicates that regular exercise can protect
individuals from a host of cardiovascular and metabolic dis-
eases (11, 19, 37). Indeed, exercise training is emerging as a
key intervention for preventive cardiology (13, 36). However,
the mechanisms by which exercise training can delay the onset
of cardiovascular diseases are not completely understood. In
the present investigation we demonstrate that exercise training
in sympathetic hyperactivity-induced HF mice 1) decreased
plasma norepinephrine levels, and 2) prevented Ca2 handling
abnormalities and cardiac dysfunction.
Sympathetic hyperactivity plays a prominent role in the
pathogenesis and evolution of cardiovascular diseases (8).
Therefore, the decreased plasma norepinephrine levels and
resting heart rate paralleled by improved fractional shortening
in exercise-trained 2A/2CARKO mice suggest the positive
impact of exercise training in the progression of HF. In fact,
therapies that reduce sympathetic tone have been associated
with a decreased risk factor for cardiovascular disease (8, 28)
and an improved prognosis (8).
The key findings of the present study are that exercise
training in 2A/2CARKO mice restored the phosphorylation
of RyR at Ser2809 to WT levels and increased the phosphory-
lation of PLN at Ser16. These results suggest that the mecha-
nisms underlying the amelioration in ventricular function in-
clude the prevention of cardiac Ca2 handling abnormalities by
changing phosphorylation status of proteins involved in sarco-
plasmic Ca2 release and reuptake.
The increased RyR phosphorylation at Ser2809 in untrained
2A/2CARKO mice was somehow expected since hyperphos-
phorylation of RyR by cAMP- and Ca2 calmodulin-depen-
dent protein kinases (PKA and CAMKII, respectively) are
commonly observed in the hyperadrenergic state (6, 33, 39).
The reduced expression of phospho-Ser2809-RyR in exercise-
trained 2A/2CARKO mice toward WT levels seems to be
beneficial because chronic hyperphosphorylation of RyR is
associated with diastolic Ca2 leak, leading to arrythmogenic-
ity (31, 35), and cardiac dysfunction. On the basis of the fact
that the reduction in phospho-Ser2809-RyR expression in exer-
cise-trained 2A/2CARKO mice paralleled the decreased
plasma norepinephrine levels, it is reasonable to speculate that
reduced RyR phosphorylation at Ser2809 is due to a decreased
sympathetic drive.
Our study regarding the expression of proteins involved in
intracellular Ca2 decline suggests that the increased phospho-
Ser16-PLN and decreased Na/Ca2 exchanger expression
levels in untrained 2A/2CARKO mice may represent a com-
pensatory mechanism against deteriorating cardiac function at
the stage of sympathetic hyperactivity-induced cardiomyopa-
thy presently studied. However, the compensatory mechanism
eventually fails in the more advanced-stage cardiomyopathy,
as we previously demonstrated by further deteriorated cardiac
function associated with reduced phosphorylation of PLN at
Ser16 and increased Na/Ca2-exchanger expression in older
2A/2CARKO mice (7 mo of age), when sympathetic hyper-
activity is associated with severe HF and 50% mortality rate
(34). In fact, increased activity of Na/Ca2 exchanger (16,
Fig. 5. Phospholamban (PLN), phospho-Ser16-PLN, and phospho-Thr17-PLN
expression in untrained and exercise-trained WT and DKO mice. Data are
presented as means 	 SE. A: representative blots of PLN, phospho-Ser16-PLN,
phospho-Thr17-PLN, and GAPDH from untrained and exercise-trained WT
and DKO mice. B–D: PLN, phospho-Ser16-PLN, and phospho-Thr17-PLN,
respectively. Targeted bands were normalized to cardiac GAPDH. *P  0.05
vs. untrained group; #P  0.05 vs. WTUN group.
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22, 38) and reduced cardiac phosphorylation of Ser16-PLN
together with increased Thr17-PLN have been reported in
end-stage HF (21, 27, 34).
Despite the fact that exercise training reduced plasma nor-
epinephrine levels in 2A/2CARKO mice, the expression of
phospho-Ser16-PLN was further increased while no changes
were observed in phospho-Thr17-PLN expression. This result
suggests that daily exercise stimulus is able to increase phos-
phorylation status of PLN at Ser16 independent of cardiac
sympathetic drive. Although the intracellular pathways in-
volved in this response remain unknown, local regulation of
PLN phosphorylation through a variety of phosphatases, ki-
nases, and kinase-anchoring proteins could be considered as
alternative mechanisms.
Recent studies have demonstrated that prior exercise training
improves hypertension-induced HF (9) and ischemia-reperfusion
injury (14) outcome, despite no changes or subtle increase in
SERCA2 expression. These results suggest that the mechanism
underlying exercise-induced cardioprotection may be influenced
by factors such as training regimen and HF etiology. Our study
shows that in a genetic model of sympathetic hyperactivity-
induced HF, exercise training restored SERCA2 expression to
control levels. In addition, Na/Ca2 exchanger expression re-
mained decreased in exercise-trained 2A/2CARKO mice. Under
this scenario, one may consider that exercise training favors Ca2
reuptake by sarcoplasmic reticulum, preventing Ca2 extrusion
by sarcolemma.
Study Limitations
Our study shows that exercise training prevents both cardiac
dysfunction and Ca2 handling abnormalities in developing
HF. However, it does not provide direct evidence to support the
cause-effect relationship between Ca2 handling protein ex-
pression and cardiac function. Although Ca2 transients tend
to parallel changes in the expression of cardiac Ca2 handling
proteins and cardiac function (1, 5, 26, 30), we did not directly
assess Ca2 transients. The data are consistent with the idea
that the changes observed by exercise training in the expression
of Ca2 handling proteins and ventricular function are attrib-
uted to an improvement of cardiac Ca2 transients.
The fractional shortening values of WT mice observed in the
present study were lower than observed in our previous work
(7). This was a matter of anesthesia used in the present study
(halothane presently used vs. isoflurane), since a fractional
shortening of 35% was observed in untrained WT mice when
echocardiography evaluations were performed under isoflurane
anesthesia. Thus the results obtained under halothane anesthe-
sia are reliable, since we could reproduce the same results
using isoflurane anesthesia, which has less impact than halo-
thane on cardiac contractility.
Conclusions
Our findings support the idea that in a setting of developing
HF, exercise training can delay cardiac dysfunction, which can
be attributed, at least in part, to a positive balance of cardiac
proteins involved in sarcoplasmic Ca2 release and reuptake.
Altogether, we provide new insights on the molecular mecha-
nisms whereby exercise training can contribute to delay cardiac
dysfunction in a genetic model of sympathetic hyperactivity-
induced HF.
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